• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接触镜:眼部药物递送的有前途的装置。

Contact lenses: promising devices for ocular drug delivery.

机构信息

Departamento de Bioquímica y Biología Molecular, Escuela Universitaria de Óptica, Universidad Complutense de Madrid, Madrid, Spain.

出版信息

J Ocul Pharmacol Ther. 2013 Mar;29(2):189-99. doi: 10.1089/jop.2012.0212. Epub 2012 Dec 5.

DOI:10.1089/jop.2012.0212
PMID:23215541
Abstract

In the ocular pharmacology market, there is a noteworthy unmet demand for more efficacious delivery of ocular therapeutics. Contact lenses are emerging as an alternative ophthalmic drug delivery system to resolve the drawbacks of the conventional topical application methods. Thus, contact lenses drug delivery systems have been developed to provide an increased residence time of the drug at the surface of the eye leading to enhanced bioavailability and more convenient and efficacious therapy. Several research groups have already explored the feasibility and potential of contact lenses loading conventional drugs used to treat anterior eye disorders. Drug incorporation to the lens body is achieved with techniques, like simple soaking, inclusion of drug-loaded colloidal nanoparticles, or molecular imprinting. Regardless of the technique used, key properties of the contact lens, such as transparency and oxygen permeability, should be preserved. In this article, we reviewed the different techniques used for drug delivery through contact lenses, analyzing their advantages and disadvantages, and focused on articles describing contact lens-based ophthalmic drug delivery systems with significant potential to use in ocular therapeutics.

摘要

在眼科药理学领域,人们对更有效地输送眼科治疗药物有明显的未满足需求。隐形眼镜作为一种替代眼科药物输送系统,正在被开发出来,以解决传统局部应用方法的缺点。因此,隐形眼镜药物输送系统已经被开发出来,以提供药物在眼睛表面的停留时间增加,从而提高生物利用度和更方便、更有效的治疗效果。已经有几个研究小组探索了将传统药物载入隐形眼镜的可行性和潜力,这些药物用于治疗前眼部疾病。将药物掺入镜片主体是通过简单浸泡、负载药物的胶体纳米粒子的包含或分子印迹等技术来实现的。无论使用哪种技术,隐形眼镜的关键特性,如透明度和氧气透过性,都应得到保留。在本文中,我们综述了通过隐形眼镜进行药物输送的不同技术,分析了它们的优缺点,并重点介绍了描述基于隐形眼镜的眼科药物输送系统的文章,这些系统具有在眼治疗中应用的巨大潜力。

相似文献

1
Contact lenses: promising devices for ocular drug delivery.接触镜:眼部药物递送的有前途的装置。
J Ocul Pharmacol Ther. 2013 Mar;29(2):189-99. doi: 10.1089/jop.2012.0212. Epub 2012 Dec 5.
2
A review on therapeutic contact lenses for ocular drug delivery.用于眼部药物递送的治疗性隐形眼镜综述。
Drug Deliv. 2016 Oct;23(8):3017-3026. doi: 10.3109/10717544.2016.1138342. Epub 2016 Jan 29.
3
Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.利用分子印迹软性隐形眼镜开发眼部给药系统。
Drug Dev Ind Pharm. 2015 May;41(5):703-13. doi: 10.3109/03639045.2014.948451. Epub 2014 Aug 12.
4
Temperature sensitive contact lenses for triggered ophthalmic drug delivery.温度敏感型接触镜用于触发式眼科药物递送。
Biomaterials. 2012 Mar;33(7):2289-300. doi: 10.1016/j.biomaterials.2011.10.076. Epub 2011 Dec 17.
5
Contact lenses for drug delivery.用于药物递送的隐形眼镜。
Semin Ophthalmol. 2009 May-Jun;24(3):156-60. doi: 10.1080/08820530902802161.
6
Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.眼用制剂和接触镜经眼部给药到前房的机制模型研究。
Adv Colloid Interface Sci. 2016 Jul;233:139-154. doi: 10.1016/j.cis.2015.08.002. Epub 2015 Aug 14.
7
Dry Eye Treatment Based on Contact Lens Drug Delivery: A Review.基于隐形眼镜药物递送的干眼治疗:综述
Eye Contact Lens. 2016 Sep;42(5):280-8. doi: 10.1097/ICL.0000000000000184.
8
Next-generation contact lenses: Towards bioresponsive drug delivery and smart technologies in ocular therapeutics.下一代隐形眼镜:眼用治疗中的生物响应药物输送和智能技术
Eur J Pharm Biopharm. 2021 Apr;161:80-99. doi: 10.1016/j.ejpb.2021.02.007. Epub 2021 Feb 16.
9
Ocular drug delivery-eye on innovation.眼部药物递送——聚焦创新
Drug Deliv Transl Res. 2016 Dec;6(6):631-633. doi: 10.1007/s13346-016-0335-6.
10
Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review.用于新型隐形眼镜基眼用药物递送系统的聚合物水凝胶:综述
Cont Lens Anterior Eye. 2008 Apr;31(2):57-64. doi: 10.1016/j.clae.2007.09.002. Epub 2007 Oct 25.

引用本文的文献

1
Design of Tranilast-Loaded Cation-Type Contact Lens for Sustainable Ocular Drug Delivery.用于可持续眼部药物递送的曲尼司特负载阳离子型隐形眼镜的设计
Pharmaceutics. 2025 May 28;17(6):712. doi: 10.3390/pharmaceutics17060712.
2
Recent Advances in Nanotechnology for the Treatment of Dry Eye Disease.用于治疗干眼症的纳米技术的最新进展
Nanomaterials (Basel). 2024 Apr 12;14(8):669. doi: 10.3390/nano14080669.
3
Current Advances in Regenerative Strategies for Dry Eye Diseases: A Comprehensive Review.干眼症再生策略的当前进展:全面综述
Bioengineering (Basel). 2023 Dec 29;11(1):39. doi: 10.3390/bioengineering11010039.
4
A novel approach to achieve semi-sustained drug delivery to the eye through asymmetric loading of soft contact lenses.一种通过软性隐形眼镜的不对称加载实现向眼睛半持续给药的新方法。
Heliyon. 2023 Jun 5;9(6):e16916. doi: 10.1016/j.heliyon.2023.e16916. eCollection 2023 Jun.
5
Review of Potential Drug-Eluting Contact Lens Technologies.药物洗脱隐形眼镜技术潜力综述
Materials (Basel). 2023 May 11;16(10):3653. doi: 10.3390/ma16103653.
6
Newer approaches to dry eye therapy: Nanotechnology, regenerative medicine, and tissue engineering.干眼症治疗的新方法:纳米技术、再生医学和组织工程。
Indian J Ophthalmol. 2023 Apr;71(4):1292-1303. doi: 10.4103/IJO.IJO_2806_22.
7
Contact lenses in dry eye disease and associated ocular surface disorders.干眼症和相关眼表疾病中的隐形眼镜。
Indian J Ophthalmol. 2023 Apr;71(4):1142-1153. doi: 10.4103/IJO.IJO_2778_22.
8
Formulation development and evaluation of therapeutic contact lens loaded with ganciclovir.载有更昔洛韦的治疗性隐形眼镜的配方开发和评估。
Int Ophthalmol. 2023 Jul;43(7):2225-2236. doi: 10.1007/s10792-022-02618-6. Epub 2023 Jan 2.
9
Cyclosporine A Delivery Platform for Veterinary Ophthalmology-A New Concept for Advanced Ophthalmology.环孢素 A 兽医眼科给药平台-高级眼科的新概念。
Biomolecules. 2022 Oct 20;12(10):1525. doi: 10.3390/biom12101525.
10
Glaucoma Treatment and Hydrogel: Current Insights and State of the Art.青光眼治疗与水凝胶:当前见解与技术现状
Gels. 2022 Aug 17;8(8):510. doi: 10.3390/gels8080510.